Page last updated: 2024-10-29

ketanserin and Primary Peritonitis

ketanserin has been researched along with Primary Peritonitis in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, H1
Altenbach, RJ1
Carr, TL1
Chandran, P1
Hsieh, GC1
Lewis, LG1
Manelli, AM1
Milicic, I1
Marsh, KC1
Miller, TR1
Strakhova, MI1
Vortherms, TA1
Wakefield, BD1
Wetter, JM1
Witte, DG1
Honore, P1
Esbenshade, TA1
Brioni, JD1
Cowart, MD1

Other Studies

1 other study available for ketanserin and Primary Peritonitis

ArticleYear
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
    Journal of medicinal chemistry, 2008, Nov-27, Volume: 51, Issue:22

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal;

2008